Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Positive interim data from controlled study of KB-109 in outpatients with COVID-19

Jan. 15, 2021

Alexion pauses enrollment in phase III study of Ultomiris for severe COVID-19

Jan. 14, 2021

'Unconventional' gamma-delta T cells recognize malaria-infected RBCs

Jan. 14, 2021

Synairgen initiates phase III study of inhaled interferon beta in hospitalized COVID-19 patients

Jan. 14, 2021

JD-1 preferentially targets cell membranes of Gram-negative bacteria

Jan. 13, 2021

U.S. researchers disclose compounds for West Nile viral infection

Jan. 13, 2021

M. tuberculosis-derived rRv-2626c-CA peptide protects mice from sepsis

Jan. 13, 2021

CureVac reports NHP data on COVID-19 vaccine candidate CVnCoV

Jan. 12, 2021

Leishmania parasites trigger SHP-1, which acts as a negative regulator of antigen cross-presentation

Jan. 12, 2021

DalCor initiates phase II study of dalcetrapib in patients with COVID-19

Jan. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...